National Institute of Environmental Health Sciences, Notice of Closed Meetings, 15313 [2016-06337]
Download as PDF
<![CDATA[
Federal Register / Vol. 81, No. 55 / Tuesday, March 22, 2016 / Notices
The registrar will also accept payment
by major credit cards (VISA/American
Express/MasterCard only). For more
information on the meeting, or for
questions on registration, contact PDA
(see FOR FURTHER INFORMATION CONTACT).
B. Accommodations
Attendees are responsible for their
own accommodations. To make
reservations, contact the Renaissance
Washington Hotel (see ADDRESSES) and
reference ‘‘the 2016 PDA/FDA Joint
Regulatory Conference’’ to receive the
PDA group rate. Room rates are: Single:
$305 plus 14.5 percent State and local
taxes. Requests will be processed on a
first-come, first-served basis.
Transcripts: As soon as a transcript is
available, it can be obtained in either
hardcopy or on CD–ROM, after
submission of a Freedom of Information
request. The Freedom of Information
office address is available on the
Agency’s Web site at https://
www.fda.gov.
Dated: March 16, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–06366 Filed 3–21–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Dated: March 15, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institute of Environmental
Health Sciences, Notice of Closed
Meetings
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Evaluation of the U01
Engineered Nanomaterials (ENMs) Grant
Applications.
Date: April 4, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Chapel Hill Hotel, 1
Europa Drive, Chapel Hill, NC 27517.
VerDate Sep<11>2014
17:34 Mar 21, 2016
Jkt 238001
Contact Person: Leroy Worth, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental
Health Sciences, P.O. Box 12233, MD EC–30/
Room 3171, Research Triangle Park, NC
27709, (919) 541–0670, worth@niehs.nih.gov.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; Small Business Innovation
Research (SBIR) Applications Teleconference
Review.
Date: April 7, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: NIEHS, Keystone Building, 530
Davis Drive, Suite 3118, Research Triangle
Park, NC 27709, (Telephone Conference
Call).
Contact Person: Leroy Worth, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental
Health Sciences, P.O. Box 12233, MD EC–30/
Room 3171, Research Triangle Park, NC
27709, (919) 541–0670, worth@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
[FR Doc. 2016–06337 Filed 3–21–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Prospective Grant of Exclusive
License: Development and
Commercialization of Cancer
Immunotherapy
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This notice, in accordance
with 35 U.S.C. 209 and 37 CFR part 404,
that the National Institutes of Health,
Department of Health and Human
Services, is contemplating the grant of
an exclusive patent license to practice
the inventions embodied in the
following U.S. Patents and Patent
Applications to Midissia Therapeutics
(‘‘MIDISSIA’’) located in San Francisco,
California, USA.
SUMMARY:
PO 00000
Frm 00094
Fmt 4703
Sfmt 4703
15313
Intellectual Property
United States Provisional Patent
Application No. 60/476,467, filed June
5, 2003, entitled ‘‘Immunogenic
Peptides and Peptide Derivatives For
The Treatment of Prostate And Breast
Cancer Treatment’’ [HHS Reference No.
E–116–2003/0–US–01]; International
Patent Application No. PCT/US2004/
17574 filed June 2, 2004 entitled
‘‘Immunogenic Peptides and Peptide
Derivatives or The Treatment of Prostate
And Breast Cancer Treatment’’ [HHS
Reference No. E–116–2003/0–PCT–02];
United States Patent No.7,541,035,
issued June 2, 2009, entitled
‘‘Immunogenic Peptides and Peptide
Derivatives For The Treatment of
Prostate And Breast Cancer Treatment’’
[HHS Reference No. E–116–2003/0–US–
03]; United States Patent No. 8,043,623,
issued 25 Oct 2011, entitled
‘‘Immunogenic Peptides and Peptide
Derivatives For The Treatment of
Prostate And Breast Cancer Treatment’’
[HHS Reference No. E–116–2003/0–US–
04]; United States Provisional Patent
Application No. 61/915,948, filed
December 13, 2013, entitled ‘‘MultiEpitope TARP Peptide Vaccine and
Uses Thereof’’ [HHS Reference No. E–
047–2014/0–US–01]; International
Patent Application No. PCT/US2014/
070144 filed December 12, 2014 entitled
‘‘Multi-Epitope TARP Peptide Vaccine
and Uses Thereof’’ [HHS Reference No.
E–047–2014/0–PCT–02]; and all
continuation applications, divisional
applications and foreign counterpart
applications claiming priority to the US
provisional application no. 61/915, 948
and U.S. Provisional Application No.
62/248,964 filed October 30, 2015 titled
‘‘Compositions and Methods for the
Treatment of HER2-Expressing Solid
Tumors’’ [HHS Reference No. E–187–
2015/0–US–01] and continuation
applications, divisional applications
and foreign counterpart applications
claiming priority to the US provisional
application no. 62/248,964.
The patent rights in these inventions
have been assigned to the government of
the United States of America.
The prospective exclusive license
territory may be worldwide and the
field of use may be limited to the use
of Licensed Patent Rights for the
following:
(1) Development and
commercialization of a therapeutic
cancer vaccine specifically in
combination with Licensee’s proprietary
or exclusively in-licensed vectors/
adjuvants and ME–TARP;
(2) Development and
commercialization of a combination
product using Licensee’s proprietary or
E:\FR\FM\22MRN1.SGM
22MRN1
]]>Agencies
[Federal Register Volume 81, Number 55 (Tuesday, March 22, 2016)]
[Notices]
[Page 15313]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-06337]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Environmental Health Sciences, Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Environmental Health
Sciences Special Emphasis Panel; Evaluation of the U01 Engineered
Nanomaterials (ENMs) Grant Applications.
Date: April 4, 2016.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Sheraton Chapel Hill Hotel, 1 Europa Drive, Chapel Hill,
NC 27517.
Contact Person: Leroy Worth, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental Health Sciences, P.O. Box
12233, MD EC-30/Room 3171, Research Triangle Park, NC 27709, (919)
541-0670, worth@niehs.nih.gov.
Name of Committee: National Institute of Environmental Health
Sciences Special Emphasis Panel; Small Business Innovation Research
(SBIR) Applications Teleconference Review.
Date: April 7, 2016.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: NIEHS, Keystone Building, 530 Davis Drive, Suite 3118,
Research Triangle Park, NC 27709, (Telephone Conference Call).
Contact Person: Leroy Worth, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Research and
Training, Nat. Institute of Environmental Health Sciences, P.O. Box
12233, MD EC-30/Room 3171, Research Triangle Park, NC 27709, (919)
541-0670, worth@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.115,
Biometry and Risk Estimation--Health Risks from Environmental
Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund Hazardous Substances--Basic
Research and Education; 93.894, Resources and Manpower Development
in the Environmental Health Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114, Applied Toxicological Research
and Testing, National Institutes of Health, HHS)
Dated: March 15, 2016.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-06337 Filed 3-21-16; 8:45 am]
BILLING CODE 4140-01-P
